InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by JOHNSON CHAD ALLEN. Director active across 2 companies, notably Lumos Pharma, INC.. Cumulatively, 3 reports have been recorded. History available since 20 May 2021. The latest transaction was filed on 20 May 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations